CIK 0001867096
- Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 871082097
- Phone
- +1 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Material agreement · Unregistered share sale · Other events
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 8-K Event Auditor change
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Material agreement
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
Page 3 of 4 · 68 filings